搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
51 分钟
Lilly and EVA Pharma announce regulatory approval and release of locally manufactured ...
The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with ...
23 小时
Our 5 Favorite Science Stories of 2024
From life-changing medical advancements to colorful auroras, this year has been packed with incredible science. It was hard ...
2 天
Frustrated with high drug costs, biohackers are reverse engineering medical treatments
Why pay $84,000 for a hepatitis C drug when you can make it at home? But such DIY chemistry raises safety concerns ...
Pharmaceutical Technology
4 天
Risk adjusted net present value: What is the current valuation of Novo Nordisk’s HS-001?
HS-001 is a cell therapy commercialized by Novo Nordisk, with a leading Phase II program in Systolic Heart Failure.
studyfinds
4 天
Scientists close to creating ‘simple pill’ that cures diabetes
Imagine a world where diabetes could be treated with a simple pill that essentially reprograms your body to produce insulin ...
PharmiWeb
5 天
Global Insulin Delivery Devices Market Poised for Significant Growth, Projected to Reach ...
A Cornerstone in Diabetes ManagementInsulin delivery devices market are innovative medical instruments designed to provide ...
jacobin
7 天
The Press Is Complicit in America’s Health Care Deaths
Major media outlets are giving wall-to-wall coverage to UnitedHealthcare CEO Brian Thompson’s murder while taking millions in ...
8 天
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.
The People's Voice
8 天
Brian Thompson's Tragic Murder
Brian Thompson's murder is a grim symbol of a larger issue: the profit-driven healthcare system in the United States, where ...
The Pharma Letter
10 天
Novo Nordisk slashes insulin prices to focus on GLP-1s
Novo Nordisk to slash US prices of Tresiba and Fiasp insulins by over 70% from 2026, enhancing diabetes access. The company ...
CTV News
11 天
Feds, province provide few details on progression of any pharmacare funding talks
While the federal and provincial governments have come to an agreement to provide access to drugs for rare diseases, neither ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈